Press news Biocartis Group NV: Biocartis Receives EUR 1.2 million Grant for Development of Highly Innovative Idylla™ GeneFusion Assay
(World News USA)

Press news Biocartis Group NV: Biocartis Receives EUR 1.2 million Grant for Development of Highly Innovative Idylla™ GeneFusion Assay 30 Sep 2020 07:00 CEST Company Name BIOCARTIS ISN BE0974281132 Market Euronext Symbol BCART Press news Biocartis Group NV: Biocartis Receives EUR 1.2 million Grant for Development of Highly Innovative Idylla™ GeneFusion Assay PRESS RELEASE: 30 September 2020, 07:00 CEST Biocartis Receives EUR 1.2 million Grant for Development of Highly Innovative Idylla™ GeneFusion Assay Mechelen, Belgium, 30 September 2020 - Biocartis Group NV (the `Company` or `Biocartis`), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that it has...